ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

Seventeen New ACS-Roosevelt Grants Awarded

July 25, 1975

NCI R01 Payline Stays At 12th Percentile for FY07.

February 9, 2007

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000

Rall Says NTP to Put 50-75 Chemicals On Long Term Tests

January 19, 1979

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989